Aldeyra Therapeutics to Join Russell Microcap Index
June 26, 2014 08:30 ET
|
Aldeyra Therapeutics
BURLINGTON, Mass., June 26, 2014 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...
Aldeyra Therapeutics Appoints Stephen Tulipano Chief Financial Officer
June 19, 2014 08:30 ET
|
Aldeyra Therapeutics
BURLINGTON, Mass., June 19, 2014 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...
Aldeyra Therapeutics Reports First Quarter 2014 Financial Results
June 11, 2014 08:30 ET
|
Aldeyra Therapeutics
BURLINGTON, Mass., June 11, 2014 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...
Aldeyra Therapeutics' Data on Lead Candidate NS2 to be Presented at Society for Investigative Dermatology 2014 Annual Meeting
May 08, 2014 08:30 ET
|
Aldeyra Therapeutics
BURLINGTON, Mass., May 8, 2014 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
Aldeyra Therapeutics Announces Closing of Initial Public Offering of 1,500,000 Shares of Common Stock
May 07, 2014 18:24 ET
|
Aldeyra Therapeutics
BURLINGTON, Mass., May 7, 2014 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
Aldeyra Therapeutics Prices Initial Public Offering of 1,500,000 Shares of Common Stock
May 01, 2014 20:30 ET
|
Aldeyra Therapeutics
BURLINGTON, Mass., May 1, 2014 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics ("Aldeyra"), a biotechnology company focused on the development of products to treat diseases where free aldehydes are thought...